GlycoMatrix™ | Lectin在各大研究的應用

GlycoMatrix™ | Lectin在各大研究的應用

2022.01.27

 

View this email in your browser

Home   |   Who We Are   |   Services   |   Distributors   |   Our Brands   |   Contact Us

Facebook

YouTube

Instagram

Website

January 2022 Newsletter

亞旭所代理的GlycoMatrix™能提供各式的研究用Lectin

特色產品

 

Oncorhynchus keta Lectin (CSL3) – Cy3


Purified CSL3 is conjugated to cyanine 3 (Cy3) fluorescent dye. Cyanine dyes are better able to withstand the harsh dehydration and embedding conditions required for mounting sections in non-polar plastic media, and are brighter in a non-polar environment than in an aqueous medium. Advantages of plastic over aqueous mounting media are brightness, contrast, and longevity of the fluorescence. Advantage of Cy3 conjugates are bright and photostable in the aqueous environment as well as in non-polar media. Cy3 has an approximate peak excitation wavelength of 550 nm and an emission wavelength at 570 nm. This product comes in a stabilized liquid form.

 

 

 

 

Hippeastrum hybrid Lectin (HHL) – Biotinylated


Affinity purified Hippeastrum hybrid lectin (HHL) is consists of four subunits of identical size. It binds only to (α-1,3) and (α-1,6) linked mannosyl units of α-mannose residues. HHL reacts not only with terminal but also with internal α-D-mannosyl residues. Lectin appears to possess extended binding sites complementary to at least three 1,6-linked α-mannosyl. HHL also binds to some yeast galactomannans. Biotin is a small molecule involved in a wide range of metabolic processes. This ligand forms a complex with Avidin and Streptavidin, resulting in the strongest non-covalent protein-ligand interaction known. Biotinylated Hippeastrum hybrid Lectin (HHL) has an appropriate amount of biotin bound to provide optimum detection characteristics when using an Avidin-HRP or Streptavidin-HRP conjugate. Biotinylated lectins allow for more sensitive detection in ELISA and Western-blotting applications.

 

 

 

 

Vicia villosa Lectin (VVL/VVA) – Biotinylated


Affinity purified Vicia villosa lectin or agglutinin (VVL/VVA) is a tetramer composed of four subunits. VVL consists of A and B subunits, with a dominant isolectin that appears to be B subunit-rich. A4 isolectin agglutinates specifically A1 erythrocytes. B4 isolectin does not agglutinate A, B, or O-erythrocytes; however, B4 binds the Tn antigen, a molecule expressed on the surface of most tumor cells. A2B2 and similar tetramer isolectins display properties characteristic of both A4 and B4 isolections.Biotin is a small molecule involved in a wide range of metabolic processes. This ligand forms a complex with Avidin and Streptavidin, resulting in the strongest non-covalent protein-ligand interaction known. Biotinylated Vicia villosa Lectin (VVL/VVA) has an appropriate amount of biotin bound to provide optimum detection characteristics when using an Avidin-HRP or Streptavidin-HRP conjugate. Biotinylated lectins allow for more sensitive detection in ELISA and Western-blotting applications.

 

 

 

精選文章

 

 

血小板研究-Jacalin

糖尿病誘導的的血小板功能障礙和糖尿病中血小板聚集可能會造成血管疾病並增加得到阿茲海默症的可能性。一項新的研究調查發現anti-α-galactoside (anti-Gal) 和anti-β-glucoside (ABG) 抗體與AOP1 和 AOP2 的蛋白結合形成三聚體。研究人員利用血小板表面 O-glycoproteins上富含serine和threonine的peptide序列作為配體來了解這些三聚體,並使用Jacalin(能專門辨識O-glycoproteins的一種Lectin)處理血小板,進一步去除三聚體複合物。

 

 

在裸露的血小板經過Jacalin 的處理,阻止了三聚體與血小板的附著並抑制了隨後的 ADP 所誘導血小板的聚集。這代表著 ADP會因為裸露的血小板表面上有大量的O-glycoproteins使血小板聚集。而 anti-Gal 和 ABG未佔據結合位點的三聚體的可能依賴於 GPIIIb/IIIa(一種較大的O-glycoproteins,是 ADP 介導的血小板活化和聚集的重要中間體)作為血小板上的配體,就像Jacalin 對裸露的血小板結合的那樣, 此數據可能為血小板脆弱性及其對糖尿病患者疾病的研究提供新的方向。

GlycoMatrix™提供高品質AIA(Jacalin) Lectin產品

21510001
Artocarpus intergrifolia (Jacalin) Lectin (AIA) – PURE

21510702
AIA – Alkaline phosphatase

21510024
AIA – Biotinylated

21510802
AIA – Colloidal Gold

21761090
AIA – Cy3

21761091
AIA – Cy5

21761003
AIA – FITC

21510025
AIA – HRP

30330081
AIA – MagneZoom Beads

 

 

20140018
AIA – Microplate

21511049
AIA – Microcolumn

20120070
AIA – OnePASS™ Separopore® Columns (Fast Flow)

21510980
AIA – OnePASS™ Separopore® Columns (Spin)

21761004
AIA – Rhodamine (TRITC)

20120001
AIA – Separopore derivatives lectin ligands (4B-CL)

21761005
AIA – Texas Red

 

膠質瘤幹細胞研究-MAA II

本月發表的一項研究,強調使用 Maackia amurensis lectin II (MAL-II) 作為研究與膠質瘤幹細胞 (GSC) 相關的sialic-acid modified glycans的工具。 膠質瘤的進展、復發和化療抗藥性可能是由於糖基化的某些改變。由於膠質瘤佔惡性腦腫瘤的 80% 以上,因此了解更多 GSC 的調節和分化是非常重要的。

研究人員發現 GSC 中結合高表現的 MAL-II,也代表著高表現的 α-2,3-sialyated glycans。此外透過 MAL-II 處理GSC使其抑制幹性和生長,進而使細胞週期停滯和凋亡。 這項研究提供了 MAL-II sialyated glycans具有潛力作為膠質瘤中潛在的幹細胞標誌物,並表示 MAL-II 可以作為抗癌藥物的可能性。

GlycoMatrix™提供高品質MAL/MAA II產品:

 

21511098
Maackia amuenis Lectin (MAL/MAA II) – Pure

21511099
MAL/MAA II – Alkaline phosphatase

21511100
MAL/MAA II – Biotinylated

21511101
MAL/MAA II – Colloidal Gold

21511109
MAL/MAA II – Cy3

21511110
MAL/MAA II Cy5

21511103
MAL/MAA II – FITC

21511104
MAL/MAA II – HRP

21511105
MAL/MAA II – MagneZoom Beads

21511106
MAL/MAA II – Rhodamine (TRITC)

21511107
MAL/MAA II – Separopore

21511108
MAL/MAA II – Texas Red

 

Citations:

Karthi, S., Sukumari-Ramesh, S., Geetha, M., & Appukuttan, P. S. (2022). High glucose removes natural anti-α-galactoside and anti-β-glucoside antibody immune complexes adhering to the surface O-glycoproteins of normal platelets and enhances platelet aggregation. Experimental and therapeutic medicine, 23(1), 82. https://doi.org/10.3892/etm.2021.11005

Putthisen, S., Silsirivanit, A., Panawan, O., Niibori-Nambu, A., Nishiyama-Ikeda, Y., Ma-In, P., Luang, S., Ohta, K., Muisuk, K., Wongkham, S., & Araki, N. (2022). Targeting alpha 2,3-sialylated glycan in glioma stem-like cells by Maackia amurensis lectin-II: A promising strategy for glioma treatment. Experimental Cell Research, 410(1), 112949. https://doi.org/10.1016/j.yexcr.2021.112949

 

 

 

 

 

 

 

back-Top
open-line

LINE 線上諮詢

亞旭-LINE-QRcode

掃瞄或手機直接點擊條碼

error: Content is protected !!